Funding is a core element of ERDERA’s strategy to transform rare disease research in Europe. Its mission is to bridge gaps in scientific knowledge, foster international collaborations, and deliver tangible benefits to millions of patients affected by rare diseases across Europe and beyond.
By pooling resources from the regional/national funding agencies, the EC, the private sector organisations, and philanthropic foundations, ERDERA drives forward groundbreaking research that has the potential to transform lives.
ERDERA’s funding research strategy is built upon a diversity of calls: Joint Transnational Calls, Clinical Trials Calls and the Networking Support Scheme. The topics of these calls will be selected by gap analysis according to the needs of the rare disease community gathered from the recommendations of the ERDERA’s advisory and governing bodies.
- Joint Transnational Calls supports interdisciplinary research to address identified gaps. These calls foster cross-border collaboration and align with the strategic priorities of the rare disease community.
- Clinical Trials Call funds controlled clinical research studies undertaken in humans to establish or confirm the safety and effectiveness of therapeutic interventions. These will benefit from ERDERA support for regulatory and methodological aspects.
- The Networking Support Scheme plays a crucial role in building the research ecosystem by fostering knowledge sharing across national and international actors, attracting underrepresented regions, engaging young researchers, and strengthening the involvement of patient organisations.
To explore the specific funding opportunities and get involved, click on the detailed sections for Joint Transnational Calls, Clinical Trials Calls, and Networking Support Scheme below.
You can also register to ERDERA’s newsletter and receive any updates directly in your inbox.
